• Wildcard: BICO, Bioprinting, and Bioconvergence

  • Dec 15 2021
  • Duração: 26 minutos
  • Podcast

Wildcard: BICO, Bioprinting, and Bioconvergence

Ouça grátis

Ver detalhes do programa

  • Sumário

  • We get back to Wednesday's healthcare roots with a rundown on BICO Group, a Sweden-based business that enables researchers and scientists to model, build, test, analyze and observe 3-D printed cells, tissues and organs.

    This company helps researchers reduce the time and cost of identifying potentially efficacious drugs and can help provide initial results on whether drug compounds are safe and effective before having to test them on animals or humans.

    We talk through the huge implications it could have for research in life sciences and personalized medicine and try to clear up some of the jargon around the company.

    Stocks: (OM:BICO)

    Check out more of our content here:

    Podcasts

    Youtube

    Twitter

    Reach us by Email @ IndustryFocus@fool.com
    Exibir mais Exibir menos
Exibir mais Exibir menos
activate_samplebutton_t1

O que os ouvintes dizem sobre Wildcard: BICO, Bioprinting, and Bioconvergence

Nota média dos ouvintes. Apenas ouvintes que tiverem escutado o título podem escrever avaliações.

Avaliações - Selecione as abas abaixo para mudar a fonte das avaliações.

Avaliações Audible.com.br

Avaliações na Amazon
Nenhuma revisão disponível